Biota Message Board - Msg: 2649626

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biota

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Craig McNeill who wrote (11)	11/5/1997 9:36:00 PM
From: A.J. Mullen	Read Replies (1) of 46

It seems to me that you know as much as I. There is a lot of excitement over Gilead. They have a richer pipeline - and eight times the capitalization. Wrt to flu though, I prefer to bet on Biota. A pill has to survive the gut and be absorbed by the body, then it must suffuse through the entire body before getting to the infected regions. Biota's line of attack, directly to the site of infection, the respiratory system seems to me (a non-medic) more hopeful. With what I regard as a potential blockbuster, I'd almost rather the company closed up all but an office to collect and distribute royalties after they fulfilled their obligations to Glaxo. Not that that is likely. The scientists must feel encouraged that they can continue their success. It is generally argued that owning foreign stocks can be helpful in reducing the overall volatility of a portfolio. The general decline in eastern markets demonstrates that there is not yet a single World Market. In that context the recent decline in BTA can be seen as positive - more so for those who didn't hold the stock during that decline.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next